These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17701193)

  • 21. Expression of cyclin D1 and retinoblastoma protein in Paget's disease of the vulva and breast: an immunohistochemical study of 108 cases.
    Ellis PE; Maclean AB; Crow JC; Wong Te Fong LF; Rolfe KJ; Perrett CW
    Histopathology; 2009 Dec; 55(6):709-15. PubMed ID: 19919588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokeratin 7 staining in mammary and extramammary Paget's disease.
    Smith KJ; Tuur S; Corvette D; Lupton GP; Skelton HG
    Mod Pathol; 1997 Nov; 10(11):1069-74. PubMed ID: 9388055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexisting vulvar Paget's disease and mucinous carcinoma of the breast: a case report and review of the literature.
    Aroonroch R; Visetsiri Y; Wongwaisayawan S; Charakorn C; Kanchanapanjapol S; Rochanawutanon M
    J Med Assoc Thai; 2012 Jun; 95(6):847-52. PubMed ID: 22774633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toker-cell pathology as a unifying concept.
    Fernandez-Flores A
    Histopathology; 2008 Jun; 52(7):889-91; author reply 891-2. PubMed ID: 18462365
    [No Abstract]   [Full Text] [Related]  

  • 25. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy.
    Plaza JA; Torres-Cabala C; Ivan D; Prieto VG
    J Cutan Pathol; 2009 Jul; 36(7):729-33. PubMed ID: 19519604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative immunohistochemical study of invasive duct carcinoma and Paget's disease of the breast with c-erbB-2 overexpression].
    Petrov SV; Raskin GA; Khasanov RSh; Tsyplakov DE
    Arkh Patol; 2006; 68(5):10-4. PubMed ID: 17144522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human epidermal growth factor receptor 2 expression in extramammary Paget's disease and mammary Paget's disease.
    Jeong SH; Hyeong JH; Park EJ; Kim KJ; Kim KH
    Australas J Dermatol; 2022 Feb; 63(1):115-118. PubMed ID: 34964488
    [No Abstract]   [Full Text] [Related]  

  • 28. HER-2/NEU overexpression in vulvar Paget disease: the Yale experience.
    Richter CE; Hui P; Buza N; Silasi DA; Azodi M; Santin AD; Schwartz PE; Rutherford TJ
    J Clin Pathol; 2010 Jun; 63(6):544-7. PubMed ID: 20418225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA; Mamoon N; Mushtaq S; Khadim MT
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases.
    Liegl B; Leibl S; Gogg-Kamerer M; Tessaro B; Horn LC; Moinfar F
    Histopathology; 2007 Mar; 50(4):439-47. PubMed ID: 17448019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of immunohistochemistry in diagnosis of breast epithelial lesions.
    Bhargava R; Dabbs DJ
    Adv Anat Pathol; 2007 Mar; 14(2):93-107. PubMed ID: 17471116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glandular Paget's disease of the nipple.
    Shousha S
    Histopathology; 2007 May; 50(6):812-4. PubMed ID: 17376174
    [No Abstract]   [Full Text] [Related]  

  • 33. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study.
    Keatings L; Sinclair J; Wright C; Corbett IP; Watchorn C; Hennessy C; Angus B; Lennard T; Horne CH
    Histopathology; 1990 Sep; 17(3):243-7. PubMed ID: 2173676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammary Paget's disease and extra-mammary Paget's disease: two morphologically similar but biologically different diseases.
    Liu W; Iqbal J; Khoury T
    J Cutan Pathol; 2010 Nov; 37(11):1145-9. PubMed ID: 19719834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
    Broom RJ; Tang PA; Simmons C; Bordeleau L; Mulligan AM; O'Malley FP; Miller N; Andrulis IL; Brenner DM; Clemons MJ
    Anticancer Res; 2009 May; 29(5):1557-62. PubMed ID: 19443366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammary and extramammary Paget's disease.
    Kanitakis J
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):581-90. PubMed ID: 17447970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathological characteristics and prognosis analysis with Paget's disease of the breast].
    Wang J; Yu WJ; Wang X; Wang X; Tian YT
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):523-527. PubMed ID: 30060361
    [No Abstract]   [Full Text] [Related]  

  • 38. Vulvar apocrine adenocarcinoma: a case with nodal metastasis and intranodal mucinous differentiation.
    Alsaad KO; Obaidat N; Dube V; Chapman W; Ghazarian D
    Pathol Res Pract; 2009; 205(2):131-5. PubMed ID: 18842349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular subtyping of mammary Paget's disease using immunohistochemistry.
    Arafah M; Arain SA; Raddaoui EMS; Tulba A; Alkhawaja FH; Al Shedoukhy A
    Saudi Med J; 2019 May; 40(5):440-446. PubMed ID: 31056619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva.
    Black D; Tornos C; Soslow RA; Awtrey CS; Barakat RR; Chi DS
    Gynecol Oncol; 2007 Mar; 104(3):547-50. PubMed ID: 17067662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.